Charleston Hematology Oncology Associates — Charleston, South Carolina

Charleston Hematology Oncology Associates is a clinical research site located in Charleston, South Carolina, United States 29414.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Charleston Hematology Oncology Associates has participated in 24 clinical trials with 2 currently active.

Therapeutic areas: Diffuse Large B-cell Lymphoma, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia.

Sponsors: MorphoSys AG, Taiho Oncology, Inc., Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charleston Hematology Oncology Associates?

Charleston Hematology Oncology Associates has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charleston Hematology Oncology Associates conducted?

Charleston Hematology Oncology Associates has 24 clinical trials on record, with 2 currently active. Their work covers Diffuse Large B-cell Lymphoma, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia.

Is Charleston Hematology Oncology Associates accredited by Crixeo Clinical Trials?

Charleston Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charleston Hematology Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.